{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T23:37:25Z","timestamp":1764805045182,"version":"3.46.0"},"reference-count":37,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Musculoskelet Radiol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The general term collagenosis covers a group of connective tissue diseases triggered by systemic autoimmune processes and as yet unknown trigger mechanisms. Systemic sclerosis is one of the five types of collagenosis. Of the systemic rheumatic diseases, it has the highest mortality rate, partly due to the historical lack of disease-modifying therapies. Early diagnosis of systemic sclerosis can be challenging if the typical symptoms and diagnostic or classification criteria are not yet evident. However, given the disease's often heterogeneous course, early diagnosis and treatment are crucial for prognosis and to protect against progression involving the internal organs. Because reliable and prognostically valid biomarkers are generally lacking, deciding whether or not to pursue aggressive treatment in the early stages of the disease remains problematic. This article discusses the potential benefits of imaging techniques such as magnetic resonance imaging and pharmacoangiography for the early diagnosis of systemic sclerosis.<\/jats:p>","DOI":"10.1055\/s-0045-1811699","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T23:33:57Z","timestamp":1764804837000},"page":"915-922","source":"Crossref","is-referenced-by-count":0,"title":["Imaging Capabilities of Patients with Early-stage Collagenoses"],"prefix":"10.1055","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4569-837X","authenticated-orcid":false,"given":"Matthias","family":"Bollow","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Augusta-Krankenanstalt Bochum, Bochum, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospital, LMU Munich, M\u00fcnchen, Germany"},{"name":"Department of Radiology, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria of the classification of systemic sclerosis (scleroderma)","volume":"23","author":"A T Masi","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"02","key":"ref2","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"E C LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"F van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref4","volume-title":"De l'asphyxie locale de la gangr\u00e8ne sym\u00e9trique des extr\u00e9mities [Local asphyxia and symmetrical gangrene of the extremities]","author":"M Raynaud","year":"1862"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1055\/s-2008-1043087","article-title":"Diagnose- und Klassifikationskriterien in der Rheumatologie: Kollagenosen","volume":"121","author":"M Zuber","year":"1996","journal-title":"Dtsch Med Wochenschr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"C P Denton","year":"2017","journal-title":"Lancet"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000501591","article-title":"Use of extracorporeal photopheresis in scleroderma: a review","volume":"236","author":"A XDu","year":"2020","journal-title":"Dermatology"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00108-019-00699-7","article-title":"Systemische sklerose","volume":"60","author":"S Schinke","year":"2019","journal-title":"Internist (Berl)"},{"issue":"09","key":"ref9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/jdv.14458","article-title":"European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes","volume":"31","author":"R Knobler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"02","key":"ref10","first-page":"276","article-title":"A survival study of patients with scleroderma diagnosed over 30 years (1953\u20131983): the value of a simple cutaneous classification in the early stages of the disease","volume":"15","author":"A J Barnett","year":"1988","journal-title":"J Rheumatol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1111\/jdv.16890","article-title":"European dermatology forum-updated guidelines on the use of extracorporeal photopheresis 2020, part 1","volume":"34","author":"R Knobler","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"07","key":"ref12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jama.1971.03180200037007","article-title":"Early fingertip changes in scleroderma","volume":"215","author":"H Y Yune","year":"1971","journal-title":"JAMA"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1007\/s00296-011-2205-3","article-title":"Evaluating hand in systemic sclerosis","volume":"32","author":"D Arslan Tas","year":"2012","journal-title":"Rheumatol Int"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.2005.044602","article-title":"Radiological hand involvement in systemic sclerosis","volume":"65","author":"J Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/archinte.1972.03650050036006","article-title":"Digital arteries in patients with scleroderma. Arteriographic and plethysmographic study","volume":"130","author":"L Dabich","year":"1972","journal-title":"Arch Intern Med"},{"key":"ref16","first-page":"262","article-title":"Arteries of the hand in patients with scleroderma","volume":"55","author":"B Janevski","year":"1986","journal-title":"Diagn Imaging Clin Med"},{"issue":"06","key":"ref17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2133.2006.07475.x","article-title":"Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis","volume":"155","author":"M Hasegawa","year":"2006","journal-title":"Br J Dermatol"},{"issue":"08","key":"ref18","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/art.22734","article-title":"Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis","volume":"56","author":"Y Allanore","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/S2665-9913(23)00189-3","article-title":"MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study","volume":"5","author":"M Hughes","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"05","key":"ref20","first-page":"503","article-title":"Prostaglandin E1 infusion for small vessel arterial ischaemia","volume":"24","author":"P C Clifford","year":"1983","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"06","key":"ref21","first-page":"953","article-title":"Prostaglandin E1 in severe Raynaud's phenomenon","volume":"92","author":"B J Pardy","year":"1982","journal-title":"Surgery"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/rheumatology\/keq268","article-title":"Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia","volume":"49","author":"S Chitale","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11926-020-00926-3","article-title":"Novel imaging strategies in systemic sclerosis","volume":"22","author":"M Wolf","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2214\/AJR.16.16366","article-title":"Abnormal bone marrow signal intensity in the phalanges of the foot as a manifestation of Raynaud phenomenon: a report of six patients","volume":"207","author":"E Smitaman","year":"2016","journal-title":"AJR Am J Roentgenol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/BOR.0000000000000965","article-title":"Raynaud phenomenon and microvasculopathy in systemic sclerosis: multi-modality imaging for diagnosis and evaluation","volume":"35","author":"G Markousis-Mavrogenis","year":"2023","journal-title":"Curr Opin Rheumatol"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/jcm10020248","article-title":"Imaging in diagnosis of systemic sclerosis","volume":"10","author":"K Rutka","year":"2021","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"102211","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"H Bukiri","year":"2022","journal-title":"Curr Opin Pharmacol"},{"issue":"25","key":"ref28","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"D P Tashkin","year":"2006","journal-title":"N Engl J Med"},{"issue":"09","key":"ref29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"D P Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/acr.23282","article-title":"Efficacy of mycophenolate mofetil and oral cyclophosphamide on skin thickness: post hoc analyses from two randomized placebo-controlled trials","volume":"70","author":"R Namas","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"24","key":"ref31","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial","volume":"311","author":"J M van Laar","year":"2014","journal-title":"JAMA"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"K M Sullivan","year":"2018","journal-title":"N Engl J Med"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0019-5154.113930","article-title":"Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations","volume":"58","author":"V Viswanath","year":"2013","journal-title":"Indian J Dermatol"},{"issue":"18","key":"ref34","first-page":"511","article-title":"Clinical, immunologic and therapeutic aspects of endangiitis obliterans","volume":"43","author":"R Lambrecht","year":"1988","journal-title":"Z Gesamte Inn Med Ihre Grenzgeb"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00393-017-0285-5","article-title":"Famili\u00e4rer Chilblain-Lupus","volume":"76","author":"C Fiehn","year":"2017","journal-title":"Z Rheumatol"},{"issue":"09","key":"ref36","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00256-023-04337-0","article-title":"Prevalence of phalangeal bone marrow edema on MRI before and during the COVID-19 pandemic and correlation with chilblain skin lesions","volume":"52","author":"L NM da Silva","year":"2023","journal-title":"Skeletal Radiol"},{"issue":"05","key":"ref37","first-page":"127","article-title":"Acquired hyperostosis syndrome (so-called pustular arthro-osteitis). Review of the literature including 73 personal cases","volume":"105","author":"W Dihlmann","year":"1993","journal-title":"Wien Klin Wochenschr"}],"container-title":["Seminars in Musculoskeletal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0045-1811699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T23:35:55Z","timestamp":1764804955000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0045-1811699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0045-1811699","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1089-7860","1098-898X"],"issn-type":[{"value":"1089-7860","type":"print"},{"value":"1098-898X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}